학술논문
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, May 2024, 202)
Subject
Language
English
ISSN
18790852
09598049
09598049